Evidence map›Paper›PMID 41145518›Full record

ArticleNature communications2025

Intrinsically accelerated cellular degradation is amplified by TDP-43 loss in ALS-vulnerable motor neurons in a zebrafish model.

Kazuhide Asakawa, Takuya Tomita, Shinobu Shioya, Hiroshi Handa, Yasushi Saeki, Koichi Kawakami

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. TDP-43: [GU]-ardian of the transcriptome.Molecular neurodegeneration · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kazuhide AsakawaNeurobiology and Pathology Laboratory, Department of Gene Function and Phenomics, National Institute of Genetics, Mishima, Shizuoka, Japan. kasakawa@nig.ac.jp.ORCID http://orcid.org/0000-0003-0628-1176
Takuya TomitaDivision of Protein Metabolism, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-4568-9940
Shinobu ShioyaNeurobiology and Pathology Laboratory, Department of Gene Function and Phenomics, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hiroshi HandaDepartment of Molecular Pharmacology, Center for Future Medical Research, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6656-9521
Yasushi SaekiDivision of Protein Metabolism, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9202-5453
Koichi KawakamiThe Graduate University for Advanced Studies (SOKENDAI), Department of Genetics, Mishima, Shizuoka, Japan.ORCID http://orcid.org/0000-0001-9993-1435

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selective neuronal vulnerability is a defining feature of neurodegenerative disorders, exemplified by motor neuron degeneration in amyotrophic lateral sclerosis (ALS). The nature of motor neurons underlying this selectivity remains unresolved. Here, by monitoring autophagy at single-cell resolution across the translucent zebrafish spinal cord, we identify motor neurons as the cell population with the highest autophagic flux. Large spinal motor neurons (SMNs), most susceptible to ALS, exhibit higher flux compared to smaller SMNs and ALS-resistant ocular motor neurons. Notably, large SMNs accelerates both autophagy and proteasome-mediated degradation, which are further augmented by TDP-43 loss. Additionally, acceleration of multiple unfolded protein response pathways indicates their innate tendency to accumulate misfolded proteins. Enhanced cellular degradation in large SMNs is neuroprotective as its inhibition halts axon outgrowth. These findings propose that cell size-associated degradation load underlies selective neuronal vulnerability in ALS, highlighting the alleviation of catabolic stress as a target of therapy and prevention.

Indexed as

Amyotrophic Lateral SclerosisDNA-Binding ProteinsMotor NeuronsZebrafish ProteinsAnimalsAutophagyDisease Models, AnimalHumansProteasome Endopeptidase ComplexProteolysisSpinal CordUnfolded Protein ResponseZebrafishDNA-Binding ProteinsProteasome Endopeptidase ComplexTardbp protein, zebrafishZebrafish Proteins

Identifiers

PMID41145518
PMCPMC12559720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.